These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8591924)

  • 1. Localization of 3H-thymidine-labeled HSV-1 in latently infected rabbit trigeminal ganglion cells.
    Green MT; Knesek JE; Dunkel EC; SeGall GK
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):394-7. PubMed ID: 8591924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
    Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
    Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
    Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of HSV-1 DNA from trigeminal ganglion neurons during suppressed infection in vitro.
    Green MT; Qavi HB; SeGall GK
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):391-4. PubMed ID: 8591923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits.
    O'Brien WJ; Tsao LS; Taylor JL
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1847-53. PubMed ID: 9727407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An in vitro study on the activation of HSV-1 latent infection in the trigeminal ganglion].
    Xie LX; Dong XG
    Zhonghua Yan Ke Za Zhi; 1994 Jan; 30(1):44-6. PubMed ID: 8082476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model.
    Bhattacharjee PS; Neumann DM; Stark D; Thompson HW; Hill JM
    Curr Eye Res; 2006 Sep; 31(9):703-8. PubMed ID: 16966142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1.
    Halford WP; Gebhardt BM; Carr DJ
    J Immunol; 1996 Oct; 157(8):3542-9. PubMed ID: 8871654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus.
    Stroop WG; Schaefer DC
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):229-37. PubMed ID: 8591901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An experimental study on HSV-1 corneal latency by in situ nucleic acid hybridization].
    Li S; Xie L; Dong X
    Zhonghua Yan Ke Za Zhi; 1995 Sep; 31(5):366-9. PubMed ID: 8706587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on herpes simplex virus-1 functional gene latency in cornea].
    Xie L; Li S; Dong X; Yuan F; Jiang Z; Shi W
    Zhonghua Yan Ke Za Zhi; 2000 Jan; 36(1):36-9. PubMed ID: 11853580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A thymidine kinase deficient HSV-2 strain causes acute keratitis and establishes trigeminal ganglionic latency, but poorly reactivates in vivo.
    Stroop WG; Banks MC; Qavi H; Chodosh J; Brown SM
    J Med Virol; 1994 Jul; 43(3):297-309. PubMed ID: 7931192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons.
    Valyi-Nagy T; Olson SJ; Valyi-Nagy K; Montine TJ; Dermody TS
    Virology; 2000 Dec; 278(2):309-21. PubMed ID: 11118355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
    Ghiasi H; Perng G; Nesburn AB; Wechsler SL
    Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
    Noisakran SJ; Carr DJ
    Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of immediate early protein ICP27/IE63 and thymidine kinase in the course of reactivation of latent herpes simplex virus 1 infection.
    Durmanová V; Rajcáni J
    Acta Virol; 2003; 47(3):159-65. PubMed ID: 14658844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia.
    Maggioncalda J; Mehta A; Su YH; Fraser NW; Block TM
    Virology; 1996 Nov; 225(1):72-81. PubMed ID: 8918535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular HSV-1 latency, reactivation and recurrent disease.
    Toma HS; Murina AT; Areaux RG; Neumann DM; Bhattacharjee PS; Foster TP; Kaufman HE; Hill JM
    Semin Ophthalmol; 2008; 23(4):249-73. PubMed ID: 18584563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
    Higaki S; Watanabe K; Itahashi M; Shimomura Y
    Curr Eye Res; 2009 Mar; 34(3):171-6. PubMed ID: 19274523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.